Akèy › Mesotelyom › Minnesota › Rochester
Etid klinik pou Mesotelyom nan Rochester, MN
5 etid pou Mesotelyom ap chèche patisipan nan sit nan ak bò kote Rochester (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Ap rekriteFaz 1
- Mayo Clinic Rochester, Rochester
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Ap rekriteEtid obsèvasyon
- Mayo Clinic Rochester, Rochester
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Ap rekriteFaz 1
- Mayo Clinic, Rochester
Lead-212 PSV359 Therapy for Patients With Solid Tumors
Ap rekriteFaz 1/2
- Mayo Clinic in Rochester, Minnesota, Rochester
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Ap rekriteFaz 1/2
- Mayo Clinic Rochester, Rochester
Etid Mesotelyom nan lòt vil
- Houston, TX15 etid
- New York City, NY10 etid
- Washington, DC9 etid
- Chicago, IL9 etid
- Nashville, TN8 etid
- Boston, MA8 etid
- Arlington, VA6 etid
- Philadelphia, PA6 etid
- Pittsburgh, PA6 etid
- Seattle, WA6 etid
- Los Angeles, CA6 etid
- Columbus, OH5 etid
Lòt etid nan Rochester
- Kansè nan tete42 etid
- Kansè Poumon ki pa ti selil37 etid
- Kansè Metastatik31 etid
- Kansè (tout kalite)30 etid
- Kansè kolorektal29 etid
- Kansè ovè29 etid
- Myelom Miltip24 etid
- Kansè pwostat22 etid
- Ensifizyans kadyak22 etid
- Kansè pankreyas22 etid
- Kansè poumon20 etid
- Kansè Endomèt20 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.